Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 57Immunoglobulin Light-chain Amyloidosis 5Smoldering Multiple Myeloma 4Plasmacytoma 3Leukemia, Plasma Cell 3Renal Insufficiency 1Recurrence 1POEMS Syndrome 1Chromosome 17 deletion 1Anemia 1Amyloidosis 1

Interventions

Dexamethasone 13Bortezomib 8Cyclophosphamide 5Lenalidomide 4pomalidomide 3isatuximab 3Calcium Dobesilate 3Thalidomide 2Kidney Transplantation 2melflufen 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1carfilzomib 1belantamab mafodotin 1auricularum 1Zoledronic Acid 1Whole-Body Irradiation 1Tablets 1Ranitidine 1Plasmapheresis 1L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1Drug Therapy 1Doxorubicin 1Diphenhydramine 1Data Collection 1Cyclosporine 1Bendamustine Hydrochloride 1BHQ880 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × auricularum × Plasma cell × Clear all
NCT04352205 2024-07-01

Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure

Emory University

Phase 2 Terminated
17 enrolled
Plasma cell

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡